Effectiveness of immunization with multi-component bacterial immunomodulator in foals at 35th day of life

Sci Rep. 2022 Sep 22;12(1):15795. doi: 10.1038/s41598-022-17532-1.

Abstract

The aim of the study was to investigate the mechanisms leading to immunization through the use of a multicomponent bacterial immunomodulator and to find out the relationship between the TLR 4 receptor with selected parameters of innate immunity and to acquire immunity. The study was conducted on 18 Polish Pony Horses foals divided into two study groups: control (n = 9) and experimental (n = 9). Foals from the experimental group received intramuscular duplicate injection of 5 ml of multi-component bacterial immunomodular at 35 and 40 days of age. RNA isolated from venous blood was used to evaluate the expression of TLR4 genes using RT-PCR. Concentration of Il-6, IL-10, IgM and IgG2 was determined by the ELISA method in blood plasma. Immunostimulation had a significant impact on the level of genes expression for TLR4 expression and IL-6 concentration. No effect of stimulation on IgM and IgG2 concentrations was found. The expression of TLR4 genes as well as the levels of interleukins could be modulated by stimulation with a pharmacological agent multi-component bacterial immunomodulator. The experiment demonstrated a strong positive correlation between TLR4 gene expression and IL-6 concentration and between TLR4 gene expression and IgM concentration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Horses
  • Immunoglobulin G
  • Immunoglobulin M
  • Immunologic Factors / pharmacology
  • Interleukin-10*
  • Interleukin-6 / genetics
  • Interleukin-6 / metabolism
  • Interleukins
  • RNA
  • Toll-Like Receptor 4* / genetics
  • Vaccination

Substances

  • Immunoglobulin G
  • Immunoglobulin M
  • Immunologic Factors
  • Interleukin-6
  • Interleukins
  • Toll-Like Receptor 4
  • Interleukin-10
  • RNA